2 Stocks That Could Be Bigger Than Shopify (TSX:SHOP)

Shopify Inc. (TSX:SHOP)(NYSE:SHOP) stock was driven by a good product in a large market. Other tech challengers could replicate the formula.

| More on:
healthcare pharma

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

After an incredible run over the past five years, Shopify (TSX:SHOP)(NYSE:SHOP) is now Canada’s most valuable publicly traded company. At the time of writing, Shopify stock is trading at $1,500 a share, implying a market capitalization of roughly $186 billion. 

Shopify’s success was no accident. Here are the factors that helped the company create shareholder value. These factors could also help emerging players become larger than Shopify over time. 

Shopify stock drivers

There are plenty of reasons why Shopify became Canada’s biggest tech company. However, the three key factors that allowed it to grow so large were great product, high margins, and a vast total addressable market. 

In other words, Shopify offered a sticky service, which has healthy gross margins in an industry (retail) that is worth over $24 trillion. The right product in a market of that size is the key driver of shareholder wealth creation over time. 

These factors could apply to two other Canadian tech companies. 

Future tech giants

One of the few industries that is as large as global retail is healthcare. This is also an industry that is just as vulnerable to disruption as retail was when people started buying stuff online. 

Global healthcare is worth $10 trillion. North America is the largest and most valuable part of that market, since our neighbor overspends on healthcare. Tight regulations and a resistance to innovation has made this market a prime target for emerging tech startups. 

Two of the most promising tech challengers are WELL Health Technologies (TSX:WELL) and CloudMD (TSXV:DOC). WELL health already offers telehealth and online pharmacy delivery services. The company’s platform includes a software product to help medical facilities manage patient data. This year, the team expanded its footprint to the U.S., which means it’s an early mover in the world’s most valuable healthcare market. 

Meanwhile, CloudMD is WELL Health’s most prominent rival. The company offers cloud-based software for medical practitioners and clinics across Canada. The company offers a mental health solution, telehealth service, and an employer-healthcare platform that puts it in close proximity to WELL Health’s offering. 

Both companies are relatively undervalued. WELL Health is worth $1.24 billion, while CloudMD is worth $424 million. While both players face rivals in America that are larger and probably better funded, the healthcare market is big enough to accommodate them all. 

In short, one or both of these companies would eventually eclipse Shopfiy’s current market cap of $186 billion. Even if they only capture a small fraction of the global healthcare market. If you’re a growth investor with a long-term time horizon, these stocks should be on your radar. 

Bottom line

Shopify is now the most valuable tech stock in the country. The combination of a massive target market, good product, and high margins helped it succeed. Shareholders who bought in early have seen their wealth expand tremendously. 

The next Shopify is likely to be driven by the same factors. This is why I believe healthtech software providers like WELL Health and CloudMD are most likely to succeed. Keep an eye on these emerging tech stars. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani owns shares of WELL Health Technologies. Tom Gardner owns shares of Shopify. The Motley Fool owns shares of and recommends Shopify and Shopify.

More on Tech Stocks

A worker uses a double monitor computer screen in an office.
Tech Stocks

Why Shopify Stock Sold Off Last Week

Shopify (TSX:SHOP) sold off heavily last week. A bad earnings release may have been the culprit.

Read more »

Hand arranging wood block stacking as step stair with arrow up.
Tech Stocks

2 Phenomenal Growth Stocks Down 30-60% That Could Rally in the Next Bull Market

Is it time to buy growth stocks? The worst of the interest rate hike and inflation is over, and now…

Read more »

stock market
Tech Stocks

2 Best Tech Stocks to Buy Before the Next Bull Market

Tech stocks such as Roku and Nuvei can help long-term investors generate outsized gains in 2023 and beyond.

Read more »

Wireless technology
Tech Stocks

Tucows Stock Trades Near its 6-Year Low: Is it a Buy?  

Tucows stock fell 63% in the tech stock sell-off and has failed to show any recovery. Is this domain and…

Read more »

Male IT Specialist Holds Laptop and Discusses Work with Female Server Technician. They're Standing in Data Center, Rack Server Cabinet with Cloud Server Icon and Visualization
Tech Stocks

Is Converge Stock a Buy?

A relatively new tech stock could soar higher with the pause in rate hikes, although a resumption of the cycle…

Read more »

online shopping
Tech Stocks

Up by 25%: Is Shopify Stock Finally a Buy in 2023?

The strong rebound in the TSX’s top tech stock remains uncertain. Investors will have to wait before it delivers stellar…

Read more »

Businessman holding AI cloud
Tech Stocks

2 TSX Tech Stocks Innovating Hard in AI

Shopify (TSX:SHOP) stock and another intriguing Canadian gem make good use of AI technologies.

Read more »

worry concern
Tech Stocks

Shopify Stock: Incredible Bargain or Deceptive Trap?

Shopify has quickly shifted from a market darling to something else. Is it a safe buy or risqué bet?

Read more »